Xintong Fan
Biographic Data
| ID | 8984067 |
|---|---|
| NAME | Xintong Fan |
| GIVEN NAMES | Xintong |
| FAMILY NAME | Fan |
| SIGNATURE | FAN X |
| AFFILIATIONS | Chinese Academy of Medical Sciences & Peking Union Medical College |
| ORCID | 0000-0002-2355-7691 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China
OBJECTIVE: To develop a multi-stakeholder, consensus-based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. METHODS: A two-round Delphi survey was conducted with a multidisciplinary expert panel (n = 62 in Round 1; n = 51 in Round 2, 82.3% retention rate) comprising clinicians, pharmacists, health administrators, and p…
The occurrence of acute primary angle closure triggered, aggravated, and accelerated by Covid-19 infection: Retrospective observational study
Introduction: The aim of this study is to demonstrate the relevance of primary acute angle closure (APAC) and COVID-19 infection, compare the demographic features and manifestations between COVID-19 positive and negative patients with APAC, and infer the underlying mechanism. Methods: This study is based on all patients diagnosed with APAC at the glaucoma center of Eye, Ear, Nose and Throat Hospital of Fudan University (Fenyang road center) from …
Posner-Schlossman syndrome relapse following inactivated Covid-19 vaccination in China
Introduction This retrospective study aims to present the characteristics of Posner-Schlossman syndrome (PSS) relapse following inactivated COVID-19 vaccination. Methods From 2020 to 2022, 12 out of 106 PSS patients undergoing relapses after any dose of inactivated COVID-19 vaccines were enrolled. Medical histories, information on the vaccination and systemic adverse events were collected. Patients were treated with corticosteroids, intraocular p…
No prominent works on this page.
The occurrence of acute primary angle closure triggered, aggravated, and accelerated by Covid-19 infection: Retrospective observational study
Introduction: The aim of this study is to demonstrate the relevance of primary acute angle closure (APAC) and COVID-19 infection, compare the demographic features and manifestations between COVID-19 positive and negative patients with APAC, and infer the underlying mechanism. Methods: This study is based on all patients diagnosed with APAC at the glaucoma center of Eye, Ear, Nose and Throat Hospital of Fudan University (Fenyang road center) from …
Posner-Schlossman syndrome relapse following inactivated Covid-19 vaccination in China
Introduction This retrospective study aims to present the characteristics of Posner-Schlossman syndrome (PSS) relapse following inactivated COVID-19 vaccination. Methods From 2020 to 2022, 12 out of 106 PSS patients undergoing relapses after any dose of inactivated COVID-19 vaccines were enrolled. Medical histories, information on the vaccination and systemic adverse events were collected. Patients were treated with corticosteroids, intraocular p…
A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China
OBJECTIVE: To develop a multi-stakeholder, consensus-based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. METHODS: A two-round Delphi survey was conducted with a multidisciplinary expert panel (n = 62 in Round 1; n = 51 in Round 2, 82.3% retention rate) comprising clinicians, pharmacists, health administrators, and p…
Internal Medicine (2 works) · Medicine (2 works) · Retinal and Optic Conditions (2 works) · Adverse effect (1 works) · China (1 works) · Delphi (1 works) · Delphi method (1 works) · Delphi Technique in Research (1 works) · Disease (1 works) · Formulary (1 works)